| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Expert on Every Street Corner? Methods for Eliciting Distributions in Geographically Dispersed Opinion Pools
|
Sperber, Daniel
|
|
2013
|
16 |
2 |
p. 434-437
4 p.
|
artikel
|
| 2 |
Assessing the Determinants of the Potential for Cost-Effectiveness Over Time: The Empirical Case of COPD
|
Refoios Camejo, Rodrigo
|
|
2013
|
16 |
2 |
p. 426-433
8 p.
|
artikel
|
| 3 |
Comparative Incidence and Health Care Costs of Medically Attended Adverse Effects among U.S. Medicaid HIV Patients on Atazanavir- or Darunavir-Based Antiretroviral Therapy
|
Johnston, Stephen S.
|
|
2013
|
16 |
2 |
p. 418-425
8 p.
|
artikel
|
| 4 |
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
|
Husereau, Don
|
|
2013
|
16 |
2 |
p. 231-250
20 p.
|
artikel
|
| 5 |
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement
|
Husereau, Don
|
|
2013
|
16 |
2 |
p. e1-e5
nvt p.
|
artikel
|
| 6 |
Copyright/Subscription
|
|
|
2013
|
16 |
2 |
p. iv-
1 p.
|
artikel
|
| 7 |
Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States
|
Stranges, Paul M.
|
|
2013
|
16 |
2 |
p. 297-304
8 p.
|
artikel
|
| 8 |
Cost-Effectiveness Analysis of Early versus Late Total Hip Replacement in Italy
|
Mújica Mota, Rubén Ernesto
|
|
2013
|
16 |
2 |
p. 267-279
13 p.
|
artikel
|
| 9 |
Cost-Effectiveness of a Program to Eliminate Disparities in Pneumococcal Vaccination Rates in Elderly Minority Populations: An Exploratory Analysis
|
Michaelidis, Constantinos I.
|
|
2013
|
16 |
2 |
p. 311-317
7 p.
|
artikel
|
| 10 |
Cost-Effectiveness of Cetuximab, Cetuximab Plus Irinotecan, and Panitumumab for Third and Further Lines of Treatment for KRAS Wild-Type Patients with Metastatic Colorectal Cancer
|
Hoyle, Martin
|
|
2013
|
16 |
2 |
p. 288-296
9 p.
|
artikel
|
| 11 |
Cost-Effectiveness of Enhancing Adherence to Therapy with Blood Pressure–Lowering Drugs in the Setting of Primary Cardiovascular Prevention
|
Scotti, Lorenza
|
|
2013
|
16 |
2 |
p. 318-324
7 p.
|
artikel
|
| 12 |
Economic Measurement of Medical Errors Using a Hospital Claims Database
|
David, Guy
|
|
2013
|
16 |
2 |
p. 305-310
6 p.
|
artikel
|
| 13 |
Editorial Board
|
|
|
2013
|
16 |
2 |
p. IFC-
1 p.
|
artikel
|
| 14 |
Erratum
|
|
|
2013
|
16 |
2 |
p. 452-
1 p.
|
artikel
|
| 15 |
Evaluating the Impact of Unmeasured Confounding with Internal Validation Data: An Example Cost Evaluation in Type 2 Diabetes
|
Faries, Douglas
|
|
2013
|
16 |
2 |
p. 259-266
8 p.
|
artikel
|
| 16 |
Evidence Synthesis Assumes Additivity on the Scale of Measurement: Response to “Rank Reversal in Indirect Comparisons” by Norton et al.
|
van Valkenhoef, Gert
|
|
2013
|
16 |
2 |
p. 449-451
3 p.
|
artikel
|
| 17 |
Hospitalization Resource Use and Costs Before and After TIA and Stroke: Results from a Population-Based Cohort Study (OXVASC)
|
Luengo-Fernandez, Ramon
|
|
2013
|
16 |
2 |
p. 280-287
8 p.
|
artikel
|
| 18 |
Improving the Quality of Papers Published in Pharmacoeconomics and Outcomes Research
|
Drummond, Michael F.
|
|
2013
|
16 |
2 |
p. 229-230
2 p.
|
artikel
|
| 19 |
Instructions for Authors
|
|
|
2013
|
16 |
2 |
p. III-IV
nvt p.
|
artikel
|
| 20 |
Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder
|
Kay, Stephen
|
|
2013
|
16 |
2 |
p. 394-402
9 p.
|
artikel
|
| 21 |
Need for Speed: An Efficient Algorithm for Calculation of Single-Parameter Expected Value of Partial Perfect Information
|
Sadatsafavi, Mohsen
|
|
2013
|
16 |
2 |
p. 438-448
11 p.
|
artikel
|
| 22 |
Patient Preferences for Biologic Agents in Rheumatoid Arthritis: A Discrete-Choice Experiment
|
Augustovski, Federico
|
|
2013
|
16 |
2 |
p. 385-393
9 p.
|
artikel
|
| 23 |
Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire Scores in Patients with Colorectal Cancer
|
Wong, Carlos King Ho
|
|
2013
|
16 |
2 |
p. 373-384
12 p.
|
artikel
|
| 24 |
Progression-Free Survival with Fulvestrant 500 mg and Alternative Endocrine Therapies as Second-Line Treatment for Advanced Breast Cancer: A Network Meta-Analysis with Parametric Survival Models
|
Cope, Shannon
|
|
2013
|
16 |
2 |
p. 403-417
15 p.
|
artikel
|
| 25 |
Quality of Life in the First 6 Weeks Following Laparoscopic and Open Colorectal Surgery
|
Dowson, Henry M.
|
|
2013
|
16 |
2 |
p. 367-372
6 p.
|
artikel
|
| 26 |
Response about Rank Reversal
|
Norton, Edward C.
|
|
2013
|
16 |
2 |
p. 451-452
2 p.
|
artikel
|
| 27 |
Table of Contents
|
|
|
2013
|
16 |
2 |
p. i-iii
nvt p.
|
artikel
|
| 28 |
The Comparison of Trial Data–Based and Registry Data–Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach
|
Lekander, Ingrid
|
|
2013
|
16 |
2 |
p. 251-258
8 p.
|
artikel
|
| 29 |
The Cost-Effectiveness of a Novel SIAscopic Diagnostic Aid for the Management of Pigmented Skin Lesions in Primary Care: A Decision-Analytic Model
|
Wilson, Edward C.F.
|
|
2013
|
16 |
2 |
p. 356-366
11 p.
|
artikel
|
| 30 |
The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain: A US Private Payer Perspective
|
Wielage, Ronald C.
|
|
2013
|
16 |
2 |
p. 334-344
11 p.
|
artikel
|
| 31 |
The Cost-Effectiveness of the Levonorgestrel-Releasing Intrauterine System for the Treatment of Idiopathic Heavy Menstrual Bleeding in the United States
|
Ganz, Michael L.
|
|
2013
|
16 |
2 |
p. 325-333
9 p.
|
artikel
|
| 32 |
Understanding the Costs of Care for Cystic Fibrosis: An Analysis by Age and Health State
|
van Gool, Kees
|
|
2013
|
16 |
2 |
p. 345-355
11 p.
|
artikel
|
Tijdschrift beschrijving